In G/GEJ tumours, CLDN18.2 is reported as the percentage of tumour cells stained with moderate-to-strong membranous stain intensity.1
Are you a healthcare professional?
This site is intended only for Healthcare Professionals who are interested in the management of gastric cancer and/or gastro-oesophageal junction cancers.
I AM NOT A HEALTHCARE PROFESSIONAL BUT WOULD LIKE MORE INFORMATION ON GASTRIC/GASTRO-OESOPHAGEAL JUNCTION CANCERS
- Tissue slides with tumour cells present can demonstrate varying levels of CLDN18 membranous staining intensity, ranging from no staining to strong staining (0 to 3+)
- Many studies have included percentage of tumour cells with only moderate-to-strong (2+/3+) membranous staining for scoring CLDN18
- Account for tumour necrosis during interpretation
Matched H&E and IHC stain of gastric tumour necrosis (10x magnification)
How to Interpret CLDN18.2
Josef H. Rüschoff, MD
Click to view stain gallery and quiz
Contact us if you’d like to know more
We are more than happy to support you in case you have questions. Feel free to reach out via e-mail.
References: 1. Pellino A, Brignola S, Riello E, et al. Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas. J Pers Med (Epub) 10-26-2021. 2. Rohde C, Yamaguchi R, Mukhina S, et al. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma. Jpn J Clin Oncol 2019;49(9):870-6.